11/4/2025NovaBridge Biosciences (I-Mab) Files for Hong Kong IPO

11/4/2025Huadong Medicine Initiates Phase I Trial of CDH17-Targeting ADC HDM201...

11/4/2025Lepu Licenses GLP-1/GIP/FGF21 Agonist MWN105 to Sidera in US$1.05B Dea...

11/4/2025CDE Seeks Comments on the 100th Batch of Reference Formulations for Ch...

11/4/2025CDE Invites Comments on the Draft Technical Guidelines for Dose Extrap...

11/4/2025NHSA Introduces New Measure to Strengthen Intelligent Oversight of Exc...

11/4/2025China's BMI Fund Maintains Strong Surplus in First Three Quarters of 2...

10/31/2025NMPA Grants Conditional Approval for Lepu Biotech's Becotatug Vedotin

10/31/2025Asia Regenerative Medicine Completes Series A Funding

10/31/2025Bayer to Divest Avelox Assets to HSG in Deal Valued up to €260 Millio...

10/31/2025Sichuan Biokin Advances 11th ADC Candidate BL-M24D1 into Clinical Tria...

10/31/2025Longwood Biopharma Secures Series B+ Funding to Accelerate Innovative ...

10/31/2025Roche Strikes Over $1B Global Licensing Deal with Qyuns Therapeutics

10/31/2025Junshi's Toripalimab Becomes First Immunotherapy Approved for NPC in C...

10/31/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China

10/31/2025China Adds Novel Drugs Catalog to National BMI Talks for the First Tim...

10/31/2025China Overhauls Drug Procurement and Reimbursement Framework to Balanc...

10/31/2025Haleon Gains Momentum in China as U.S. Sales Remain Weak

10/31/2025GC Cell Licenses IASO Biotech's Multiple Myeloma CAR-T Therapy for Kor...

10/31/2025CDE Invites Comment on Implementation Guidance for ICH Q8, Q9 and Q10 ...

10/31/2025China's Biotech Deal Boom Tests Ethical Boundaries as Valuations Soar ...

10/29/2025China Pushes Ethical Limits in Global Biotech Race With Gene-Edited An...

10/29/2025Abbisko Presents Promising Preclinical Data on Novel CDK4/2 Inhibitor ...

10/29/2025NMPA Approves Huadong Pharma's Mifanertinib Maleate for EGFR-Mutant NS...

10/29/2025Immunofoco Raises Series B+ Funding to Advance CAR-T Platforms for Sol...

10/29/2025Pharmaron to Acquire Biortus in China

10/29/2025NMPA Seeks Comments on Revised GCP Draft for Drug Trials

10/29/2025CDE Issues Draft Guidelines on Including Geriatric Use Information in ...

10/29/2025CDE Issues Guidance on Key Elements and Trial Design for Elderly Parti...

10/29/2025CDE Issues Guidance on Age-Friendly Design Principles for Innovative D...

Page:18/814 Total number of articles:24415: [First][<<] [16] [17] [18] [19] [20] [>>] [End]